FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Flu Vaccine Adjuvant Safety is Open for Questions

[ Price : $8.95]

This story has been removed because it contained factual errors.

Sanofi-Aventis Says More Info Needed in Postmarketing Guidance

[ Price : $8.95]

Sanofi-Aventis tells FDA there are aspects of its draft guidance on postmarketing requirements and commitments that need additiona...

Advisors Asked to Evaluate Fampridine SR Efficacy, Safety

[ Price : $8.95]

FDA asks the Peripheral and Central Nervous System Drugs Advisory Committee to evaluate safety and effectiveness of Acordas fampri...

Former Biopure Regulatory Affairs Official Sentenced

[ Price : $8.95]

A federal court has sentenced a former Biopure regulatory affairs official to 36 months in prison for lying to a federal judge tha...

FDA Publishes Assay Class 2 Special Controls Guidance

[ Price : $8.95]

FDA publishes a guidance to support a Class 2 special controls designation for respiratory viral panel multiplex nucleic acid assa...